ESC Premium Access

Guidelines: commonalities and discrepancies.


Topic: Lipids
Sponsored by Sanofi and Regeneron

Congress Presentation

About the speaker

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

6 more presentations in this session

Introduction - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor C. Cannon (Boston, US)


LDL-C exposure and atherosclerosis progression.

Speaker: Professor A. Catapano (Milan, IT)


PCSK9 inhibition: the data today and tomorrow.

Speaker: Professor S. Nicholls (Melbourne, AU)


Learnings and clinical insights from SPIRE.

Speaker: Doctor P. Ridker (Boston, US)


Identifying appropriate patients to treat: a case-based approach.

Speaker: Professor C. Cannon (Boston, US) Professor A. Catapano (Milan, IT) Professor S. Nicholls (Melbourne, AU) Doctor P. Ridker (Boston, US) Doctor J. Robinson (Iowa, US)


Access the full session

PSCK9 inhibition: a new horizon in LDL-C management

Speakers: Doctor J. Robinson, Professor C. Cannon, Professor A. Catapano, Professor S. Nicholls, Doctor P. Ridker...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb